Home/Filings/3/0000950170-23-060594
3//SEC Filing

Atlas Venture Associates XI, L.P. 3

Accession 0000950170-23-060594

CIK 0001703647other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 9:05 PM ET

Size

14.6 KB

Accession

0000950170-23-060594

Insider Transaction Report

Form 3
Period: 2023-11-03
Holdings
  • Common Stock

    177,217
  • Common Stock

    (indirect: See Footnote)
    942,075
Holdings
  • Common Stock

    177,217
  • Common Stock

    (indirect: See Footnote)
    942,075
Holdings
  • Common Stock

    (indirect: See Footnote)
    942,075
  • Common Stock

    177,217
Holdings
  • Common Stock

    177,217
  • Common Stock

    (indirect: See Footnote)
    942,075
Holdings
  • Common Stock

    177,217
  • Common Stock

    (indirect: See Footnote)
    942,075
Holdings
  • Common Stock

    177,217
  • Common Stock

    (indirect: See Footnote)
    942,075
Footnotes (2)
  • [F1]The shares are owned directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). Atlas Venture Associates Opportunity II, L.P. ("AVAO II LP") is the general partner of AVOF II. Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. Each of AVAO II LP and AVAO II LLC disclaims beneficial ownership of the securities held by AVOF II, except to the extent of its pecuniary interest therein, if any.
  • [F2]The shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI"). The general partner of Atlas Venture Fund XI is Atlas Venture Associates XI, L.P. ("AVA XI LP"). Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. Each of AVA XI LP and AVA XI LLC disclaims beneficial ownership of the securities held by Atlas Venture Fund XI, except to the extent of its pecuniary interest therein, if any.

Documents

1 file

Issuer

Korro Bio, Inc.

CIK 0001703647

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001780068

Filing Metadata

Form type
3
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 9:05 PM ET
Size
14.6 KB